Scorpio- HR Activ 2-D

COVID-19 Treatment Study

The purpose of the study is to evaluate the ability of an experimental oral drug called S-217622 to improve the health of people with recent COVID-19. 

We are looking for people who are at least 18 years old and who,in the last few days, tested positive for SARS-CoV-2.

Join this Study